Announced Wed, 7 Oct, 2026 · 19:32 IST
Rekvina Labs appoints Subrata Samanta as CFO effective Oct 7, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Rekvina Laboratories board appointed Mr. Subrata Samanta as Chief Financial Officer and Key Managerial Personnel, effective October 7, 2026. He has 20+ years of finance and costing experience at firms like GNFC, Lupin, Glenmark, Intas, and PwC. He holds an M.Com from Calcutta University and is an ACMA. SEBI has not debarred him. Board meeting ran 6:50 p.m. to 7:15 p.m.
Likely market impact
New CFO with strong pharma finance background. Positive for governance; limited direct impact on stock price.